Alpha 2.0
Login Register
» Articles » PMID: 30023897

Indium/Gallium Maltolate Effects on Human Breast Carcinoma Cells: In Vitro Investigation on Cytotoxicity and Synergism with Mitoxantrone

Overview
Journal ACS Omega
Publisher American Chemical Society
Specialty Chemistry
Date 2018 Jul 20
PMID 30023897
Citations 7
Authors
Daniele Merli
Antonella Profumo
Nora Bloise
Giulia Risi
Stefano Momente
Lucia Cucca
Livia Visai
Affiliations
Soon will be listed here.
Abstract

In this study, we aimed to investigate in vitro whether the synthetized indium maltolate (InMal) and gallium maltolate (GaMal) could exert either a toxic effect toward breast cancer cell line MDA-MB-231 or an agonistic activity with mitoxantrone (MTX) in comparison to fibroblast cell line NIH-3T3. Both GaMal and InMal reduced viability of MDA-MB-231, and at a lesser extent of NIH3-T3, in a dose- and time-dependent mode, the outcome was more effective in comparison to MTX sole exposure. Both GaMal and InMal toxicity was reverted by iron citrate addition on NIH3-T3, not on MDA-MB-231, showing indirectly that gallium and indium's mechanisms of action may include iron targeting. The agonistic activity against MDA-MB-231 survival was shown pretreating with 100 μM InMal for 24 h followed by medium exchange with MTX at 10 ng mL or vice-versa but not with co-incubation of both compounds. In particular, InMal pretreating resulted more protective to MTX subsequent exposure.

Citing Articles

and studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma.

Moawed F, Haroun R, Abou Zaid E, Mansour S, Badawi A, Kandil E Int J Immunopathol Pharmacol. 2023; 37:3946320231180708.

PMID: 37276131 PMC: 10262667. DOI: 10.1177/03946320231180708.

Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells.

Chen C, Huang Y, Grillet L, Hsieh Y, Yang Y, Lo K Cell Oncol (Dordr). 2023; 46(4):1127-1142.

PMID: 37067747 DOI: 10.1007/s13402-023-00804-x.

Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.

Kontoghiorghes G Int J Mol Sci. 2023; 24(5).

PMID: 36902402 PMC: 10002863. DOI: 10.3390/ijms24054970.

Solution speciation and human serum protein binding of indium(III) complexes of 8-hydroxyquinoline, deferiprone and maltol.

Domotor O, Keppler B, Enyedy E J Biol Inorg Chem. 2022; 27(3):315-328.

PMID: 35243522 PMC: 8960621. DOI: 10.1007/s00775-022-01935-6.

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.

Kontoghiorghes G, Kolnagou A, Demetriou T, Neocleous M, Kontoghiorghe C Int J Mol Sci. 2021; 22(11).

PMID: 34074010 PMC: 8197347. DOI: 10.3390/ijms22115546.

References
1.
Torti S, Torti F . Ironing out cancer. Cancer Res. 2011; 71(5):1511-4. PMC: 3079335. DOI: 10.1158/0008-5472.CAN-10-3614. View
2.
Collery P, Keppler B, Madoulet C, Desoize B . Gallium in cancer treatment. Crit Rev Oncol Hematol. 2002; 42(3):283-96. DOI: 10.1016/s1040-8428(01)00225-6. View
3.
CAILLEAU R, Young R, Olive M, REEVES Jr W . Breast tumor cell lines from pleural effusions. J Natl Cancer Inst. 1974; 53(3):661-74. PMC: 7364228. DOI: 10.1093/jnci/53.3.661. View
4.
Maduray K, Odhav B . The in vitro photodynamic effect of laser activated gallium, indium and iron phthalocyanine chlorides on human lung adenocarcinoma cells. J Photochem Photobiol B. 2013; 128:58-63. DOI: 10.1016/j.jphotobiol.2013.08.003. View
5.
Fecteau M, Aceto H, Bernstein L, Sweeney R . Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro. Vet J. 2014; 202(1):195-7. DOI: 10.1016/j.tvjl.2014.06.023. View